Corpus Intelligence DCF — HEALTHALLIANCE-CLINTON 2026-04-26 02:07 UTC
DCF — HEALTHALLIANCE-CLINTON
Enterprise Value: $-168.6M
🛡️ Public data only — no PHI permitted on this instance.
$-168.6M
Enterprise Value
$-56.4M
PV of Cash Flows
$-112.2M
PV of Terminal Value
$-180.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$196.3M$-8.8M-5.0%$-17.1M$-15.6M
Year 2$202.2M$-7.1M-4.0%$-15.6M$-12.9M
Year 3$208.3M$-5.2M-3.0%$-14.0M$-10.5M
Year 4$214.5M$-4.3M-2.0%$-13.4M$-9.1M
Year 5$220.9M$-3.9M-2.0%$-13.2M$-8.2M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-168.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$190.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000157413669
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5